Press Release

Cord Blood America Announces Marketing Alliance Between CorCell and Mountain State Blue Cross Blue Shield, West Virginia

Los Angeles, CA and Philadelphia, PA (December 11, 2006) – Cord Blood America, Inc. (OTC BB: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally,

announced today that CorCell, Philadelphia, Pa., whose operating entity and assets were recently purchased by the Company, has signed a marketing alliance with Mountain State Blue Cross Blue Shield (MSBCBS), the largest health insurer in West Virginia.

"This alliance will bring the knowledge and awareness to MSBCBS members, providers and corporate, union and government employer groups of the significant value of storing umbilical cord blood stem cells. Mountain State Blue Cross Blue Shield selected CorCell to offer the service to all its members as a strategic value added program and CorCell will offer a preferred price for the cord blood banking service," said Marcia Laleman, CorCell's President.

CorCell is a national leader in private family cord blood banking. It is the fourth largest private umbilical cord blood bank in the U.S. Cord blood stem cells may be used today to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies with many additional uses currently under investigation in clinical trials. Previously the umbilical cord, which contains a rich store of stem cells, had been thrown away at birth.

"The CorCell cord blood banking program offers our members access to crucial information and services that can safeguard their families' health and well being. As a health insurer absolutely committed to the long term well being of West Virginians, we know that umbilical cord blood stem cell storage will be a valuable resource for future disease treatments," said Gregory Smith, President and CEO of Mountain State Blue Cross Blue Shield.

Mountain State Blue Cross Blue Shield serves the entire state of West Virginia and Washington County, Ohio, providing health care coverage for more than 425,000 members. Mountain State Blue Cross Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield Plans.

"Cord Blood America is delighted to welcome the families of Mountain State Blue Cross Blue Shield into CorCell's 'Saving Baby's Cord Blood' program. We look forward to the continued growth of our strategic partnerships for the benefit of our Company, its shareholders and families throughout America," said Matthew Schissler, CEO.

About Cord Blood America
Cord Blood America (OTC BB:CBAI.OB -News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. For investor information on Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit www.cordblood-america.com.

Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as “anticipate,” “believe,” “expect,” “future,” “intend,” “plan,” and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company’s performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company’s public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company’s past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

Read more Press Releases by following this link: CorCell Cord Blood Bank News.